US EditionPublished • loading... • Updated
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation
The Rosen Law Firm investigates a 19.9% stock drop after Tandem Diabetes issued a voluntary correction for insulin pumps that could disrupt insulin delivery.
- The Rosen Law Firm, P.A. is investigating potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. , the firm said in New York on Dec. 5, 2025.
- The Aug. 7, 2025 device-correction notice from Tandem described the underlying issue, announcing a voluntary medical device correction for select t:slim X2 insulin pumps to address a potential speaker-related error.
- Tandem Diabetes Care stock plunged 19.9% on August 7, 2025, after its device correction, while The Rosen Law Firm, P.A. highlighted its $438 million 2019 recovery.
- Preparing a class action, The Rosen Law Firm, P.A. seeks to recover investor losses related to Tandem Diabetes securities and offers compensation without out-of-pocket fees.
- Prospective class members can contact Phillip Kim, Esq. or use Rosen Law's online submission portal to join, with toll-free 866-767-3653 provided and a disclaimer on prior results.
Insights by Ground AI
23 Articles
23 Articles
The Bakersfield Californian+2 Reposted by 2 other sources
Rosen Law Firm Encourages Balancer Cryptocurrency Investors to Inquire About Securities Class Action Investigation
NEW YORK--(BUSINESS WIRE)--Dec 5, 2025-
·Bakersfield, United States
Read Full Article
Coverage Details
Total News Sources23
Leaning Left4Leaning Right1Center12Last UpdatedBias Distribution71% Center
Bias Distribution
- 71% of the sources are Center
71% Center
L 23%
C 71%
Factuality
To view factuality data please Upgrade to Premium
